Prescription drug · NDA
Rocklatan NDC 70727-529
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% · Netarsudil mesylate .2 mg/mL; Latanoprost .05 mg/mL · Solution/ drops · Ophthalmic, Topical · Alcon Laboratories, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70727-529-25 | 70727052925 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTICMarketed from Mar 12, 2019 | |
| 70727-529-99 | 70727052999 | 1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTICMarketed from Mar 12, 2019 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rocklatan
- Generic name (nonproprietary)
- netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
- Active ingredients
- Netarsudil mesylate — .2 mg/mLLatanoprost — .05 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic, Topical
- Labeler
- Alcon Laboratories, Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208259
- Marketing start
- Listing expires
- Other FDA classes
- Rho Kinase Inhibitors (Mechanism)
- Identifiers
- Product ID 70727-529_1972fd8e-f2ee-40d9-aa87-c7263b6d952eSPL ID 1972fd8e-f2ee-40d9-aa87-c7263b6d952eSPL set ID b1d71f41-be06-4a08-94d4-e352198f09c2RxCUI 2119701, 2119706UNII VL756B1K0U, 6Z5B6HVF6OUPC 0370727529253
- Pharmacologic class
- Rho Kinase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic, Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470727052925followed by a unit qualifier and the quantityPackage 70727-0529-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. INDICATIONS AND USAGE ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ROCKLATAN ® is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.